financetom
Business
financetom
/
Business
/
Corcept Therapeutics Insider Sold Shares Worth $1,400,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Corcept Therapeutics Insider Sold Shares Worth $1,400,000, According to a Recent SEC Filing
May 16, 2024 12:24 AM

03:12 AM EDT, 05/16/2024 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on May 13, 2024, sold 50,000 shares in Corcept Therapeutics ( CORT ) for $1,400,000. Following the Form 4 filing with the SEC, Maduck has control over a total of 105,222 shares of the company, with 85,222 shares held directly and 20,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017024060767/xslF345X03/ownership.xml

Price: 27.16, Change: -0.67, Percent Change: -2.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved